DEA schedule
Is Synjardy a controlled substance?
Synjardy contains empagliflozin and metformin. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Synjardy (empagliflozin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and empagliflozin and metformin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Synjardy?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 8 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | empagliflozin and metformin is not on the list |
Synjardy NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0597-0168 | Synjardy | tablet | 12.5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0180 | Synjardy | tablet | 12.5 mg/1; 500 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0175 | Synjardy | tablet | 5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0159 | Synjardy | tablet | 5 mg/1; 500 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0280 | Synjardy XR | tablet, extended release | 10 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0300 | Synjardy XR | tablet, extended release | 12.5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0295 | Synjardy XR | tablet, extended release | 25 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0290 | Synjardy XR | tablet, extended release | 5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
Questions
Is Synjardy a controlled substance?
No. Synjardy (empagliflozin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and empagliflozin and metformin is not on the DEA controlled substances list.
Is Synjardy a narcotic?
No. Synjardy (empagliflozin and metformin) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Biguanide and Sodium-Glucose Cotransporter 2 Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Synjardy
- What is Synjardy used for?FDA label uses
- Generic for SynjardyFDA Orange Book
- Is Empagliflozin and Metformin a controlled substance?Federal schedule
- Generic for Synjardy XRFDA Orange Book
- Biguanides listFDA drug class
- Sodium-Glucose Cotransporter 2 Inhibitors listFDA drug class
- Synjardy Medicare Part D coverageBy plan and state
- NDC 0597-0159Synjardy NDC record
- NDC 0597-0168Synjardy NDC record
- NDC 0597-0175Synjardy NDC record